BioNTech SE 20-F for FY2023
BioNTech SE (BNTX)
20-F
2024-03-20
For: 2023-12-31
View Original
Added on
April 07, 2026
About this 20-F
BioNTech SE filed this 20-F on March 20, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 3.82B EUR
- down 77.9% from 17.31B EUR a year earlier
- Net income
- 930.3M EUR
- down 90.1% from net income of 9.43B EUR a year earlier
- Diluted EPS
- 3.83 EUR
- down 89.9% from 37.77 EUR a year earlier